Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • STM vs MRNA✓SelectedUSD · MRNASTM vs MRNA performance historyLatest closeAs of-10.67%11/20
Stock and ETF performance explorer

STM vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-12.9%
MRNA return
+153.9%
Excess return
-166.8%
Maximum drawdown
-64.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-10.7%-2.2%-8.5%-10.5%
7D-16.3%-12.7%-3.6%-15.7%
30D-17.5%-20.7%+3.1%-16.6%
3M-21.5%+46.3%-67.8%-23.3%
6M-39.6%+305.2%-344.8%-50.1%
YTD+51.6%+561.2%-509.6%+8.7%
1Y+86.2%+772.1%-685.9%+23.8%
3Y-12.9%+147.0%-159.8%-30.3%
All-12.9%+153.9%-166.8%-30.3%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling